SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 187 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.83 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,062,000 | -29.9% | 228,810 | -6.9% | 0.39% | -30.5% |
| Q2 2021 | $2,941,000 | -14.0% | 245,718 | -9.9% | 0.56% | -22.6% |
| Q1 2021 | $3,418,000 | +615.1% | 272,801 | +789.9% | 0.72% | +511.0% |
| Q4 2020 | $478,000 | +133.2% | 30,655 | +41.2% | 0.12% | +93.4% |
| Q3 2020 | $205,000 | +0.5% | 21,710 | -4.8% | 0.06% | -14.1% |
| Q2 2020 | $204,000 | +46.8% | 22,800 | +4.6% | 0.07% | +22.4% |
| Q1 2020 | $139,000 | -20.1% | 21,800 | +4.8% | 0.06% | +11.5% |
| Q4 2019 | $174,000 | +58.2% | 20,800 | +71.9% | 0.05% | +44.4% |
| Q3 2019 | $110,000 | – | 12,100 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
| NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
| Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
| WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
| Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
| Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
| Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
| Leisure Capital Management | 43,008 | $131,000 | 0.12% |
| Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |